About Well Genetics
Well Genetics is a company based in Taipei (Taiwan) founded in 2014. Well Genetics offers products and services including Drosophila Genome Editing Services, Drosophila Microinjection Services, CRISPR Microinjection Services, Non-melanogaster Microinjection Services, and Fly Food in Vial. Well Genetics operates in a competitive market with competitors including Rejuvenate Bio, Novogene Corporation, Clinical Microbiomics, BGI and Genewiz, among others.
- Headquarter Taipei, Taiwan
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Wellgenetics Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$59.96 K (USD), Grant
May 01, 2018
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Well Genetics
Well Genetics offers a comprehensive portfolio of products and services, including Drosophila Genome Editing Services, Drosophila Microinjection Services, CRISPR Microinjection Services, Non-melanogaster Microinjection Services, and Fly Food in Vial.
Services for precise genome modifications in fruit flies for research.
Techniques for injecting genetic materials into fly embryos.
CRISPR-based services for targeted gene editing in insects.
Microinjection for species beyond Drosophila melanogaster.
Pre-packaged food for maintaining and culturing fruit flies.
Funding Insights of Well Genetics
Investors in Well Genetics
Well Genetics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Well Genetics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Well Genetics
Investment portfolio details for Well Genetics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Well Genetics
Detailed financials for Well Genetics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Well Genetics Comparisons
Peer comparison for Well Genetics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Well Genetics
Well Genetics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Rejuvenate Bio, Novogene Corporation, Clinical Microbiomics, BGI and Genewiz, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Gene-editing platform and anti-aging therapy for dogs are developed.
|
|
| Locked | Locked | Locked |
Genomic services and solutions with NGS expertise are provided.
|
|
| Locked | Locked | Locked |
Meta-genomics platforms and services for microbiome studies are provided.
|
|
| Locked | Locked | Locked |
BGI is engaged in genomics and precision medicine solutions.
|
|
| Locked | Locked | Locked |
Genomic services are provided for the life sciences industry.
|
|
| Locked | Locked | Locked |
NGS-based diagnostic solutions for neonatal screening are developed.
|
Detailed competitors of Well Genetics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Well Genetics
Complete news archive for Well Genetics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Well Genetics
Well Genetics was founded in 2014 and raised its 1st funding round 4 years after it was founded.
Well Genetics is headquartered in Taipei, Taiwan.
Well Genetics was founded in 2014 in Taipei, Taiwan, within the biotechnology sector. Genome editing services utilizing CRISPR technology are provided, with a focus on Drosophila applications. Microinjection services for Drosophila and mosquitoes are included in the portfolio. Fly food packaged in vials for Drosophila research is manufactured and distributed. Operations support genetic studies in model organisms.
Well Genetics's top competitors include Novogene Corporation, BGI and Source BioScience.
Well Genetics offers Drosophila Genome Editing Services, Drosophila Microinjection Services, CRISPR Microinjection Services, Non-melanogaster Microinjection Services, and Fly Food in Vial.
Well Genetics has 1 investor. Key investors include European Union.